信州大学HOMEENGLISH交通・キャンパス案内

研究者総覧研究者総覧

研究者、研究内容などで検索
項目別検索はこちら

大神田 淳子  オオカンダ ジュンコ

教員組織学術研究院(農学系)電話番号
教育組織農学部 農学生命科学科 生命機能科学コースFAX番号
職名教授メールアドレスjohkanda@shinshu-u.ac.jp
住所〒399-4598 長野県上伊那郡南箕輪村8304ホームページURLhttp://www.shinshu-u.ac.jp/faculty/agriculture/lab/johkanda/index.html

プロフィール

研究分野
生物有機化学
化学生物学
キーワード:たんぱく質間相互作用 , 天然変性たんぱく質 , 医農薬開発 , 抗がん剤 , シグナル伝達系 , 翻訳後修飾 , 天然物 , ペプチド , 14-3-3たんぱく質
現在の研究課題
たんぱく質間相互作用を調節する合成分子の創製
キーワード:中分子
所属学会
所属学会
日本化学会
日本薬学会
有機合成化学協会
日本農芸化学会
アメリカ化学会
近畿化学協会

所属学会役職担当
2021- , 日本薬学会 , 代議員
2020- , 日本化学会生体機能関連化学・バイオテクノロジーディビジョン , 副主査
2018- , 近畿化学協会 , 代議員
2017-2019 , 日本農芸化学会 , 学術活動強化委員会委員
2008- , 日本化学会フロンティア生命化学研究会 , 理事(レター編集担当)
学歴
出身大学院
1996 , 東京大学 博士(工学)
1990 , お茶の水女子大学大学院 , 理学研究科 , 化学専攻 修士課程

取得学位
博士(工学) , 東京大学
受賞学術賞
2017 , 長瀬研究振興賞
2016 , 第21回日本女性科学者の会奨励賞
2008 , 日本学術振興会平成20年度科学研究費補助金第1段審査員表彰
研究職歴等
研究職歴
2016- , 信州大学学術研究院(農学系)教授
2013-2016 , 京都大学化学研究所准教授
2005-2013 , 大阪大学産業科学研究所准教授
2004-2005 , 東京学芸大学専任講師
2003-2003 , アキリオン製薬創薬部門研究員(米国コネチカット州)
1998-2003 , エール大学化学科博士研究員
1991-1997 , 成蹊大学工学部助手
1990-1991 , (株)リコー中央研究所研究員

研究職歴以外の職歴
2020- , 科学技術振興機構創発的研究支援事業創発アドバイザー
2017- , Bioorganic Chemistry Editorial board member (Elsevier)

研究活動業績

研究業績(著書・
発表論文等)
書籍等出版物
Chemical approach toward controlling of transient protein interactions, Chemical approach toward controlling of transient protein interactions, published in Middle Molecular Strategy, 77-96
Springer, Singapore 2021(Jul. 14)
Author:Junko Ohkanda


Self-Assembled Receptors for Protein Surface Recognition, Self-assembled receptors for protein surface recognition, published in Comprehensive Supramolecular Chemistry II, 351-369
Elsevier, Oxford 2017
Author:Junko Ohkanda


論文
Design, synthesis, and functional evaluation of triazine-based bivalent agents that simultaneously target the active site and hot spot of phosphatase Cdc25B
Bioorg. Med. Chem. Lett.,in press. 2021(Jul. 12)
Author:Yosei Nagaoka, Prakash Parvatkar, Go Hirai, Junko Ohkanda


Intrinsically Disordered Proteins as Regulators of Transient Biological Processes and as Untapped Drug Targets
MOLECULES,26(8) 2021(Apr.)
Author:Hosoya, Yusuke; Ohkanda, Junko;
Keywords:intrinsically disordered proteins; protein– protein interactions; liquid– liquid phase separation; drug discovery;


Fusicoccin: A Chemical Modulator for 14-3-3 Proteins
CHEMISTRY LETTERS,50(1):57-67 2021(Jan.)
Author:Ohkanda, Junko;
Keywords:Stabilizers and inhibitors; Protein-protein interactions; Antitumor agents;


Identification of synthetic inhibitors for the DNA binding of intrinsically disordered circadian clock transcription factors
Chemical Communications,56:11203-11206 2020(Aug. 21)
Author:Yusuke Hosoya, Wataru Nojo, Isao Kii, Takanori Suzuki, Miki Imanishi, Junko Ohkanda


A NOVEL CONDENSED HETEROCYCLIC QUINONE WITH A DIBENZOFURANOBISTHIADIAZOLE SKELETON
HETEROCYCLES,101(1):99-103 2020
Author:Sugawara, Kazuma; Nojo, Wataru; Ishigaki, Yusuke; Ohkanda, Junko; Suzuki, Takanori;
Keywords:Quinone; Intermolecular Interaction; Oxidation; Condensation; Charge-Transfer;


Copper-Free Huisgen Cycloaddition for the 14-3-3-Templated Synthesis of Fusicoccin-Peptide Conjugates
CHEMISTRY-AN ASIAN JOURNAL,15:742-747 2020
Author:Masuda, Ryoma; Kawasaki, Yuuya; Igawa, Kazunobu; Manabe, Yoshiyuki; Fujii, Hiroshi; Kato, Nobuo; Tomooka, Katsuhiko; Ohkanda, Junko;


Dipicolylamine/Metal Complexes that Promote Direct Cell-Membrane Penetration of Octaarginine
BIOCONJUGATE CHEMISTRY,30(2):454-460 2019(Feb.)
Author:Kawaguchi, Yoshimasa; Ise, Shoko; Azuma, Yusuke; Takeuchi, Toshihide; Kawano, Kenichi; Toan Khanh Le; Ohkanda, Junko; Futaki, Shiroh;


A Guanidyl-Based Bivalent Peptidomimetic Inhibits K-Ras Prenylation and Association with c-Raf
CHEMISTRY-A EUROPEAN JOURNAL,25(59):13531-13536 2019
Author:Tsubamoto, Mai; Toan Khanh Le; Li, Minghua; Watanabe, Taku; Matsumi, Chiemi; Parvatkar, Prakash; Fujii, Hiroshi; Kato, Nobuo; Sun, Jiazhi; Ohkanda, Junko;


Structural Effects of Fusicoccin upon Upregulation of 14-3-3-Phospholigand Interaction and Cytotoxic Activity
CHEMISTRY-A EUROPEAN JOURNAL,24(60):16066-16071 2018
Author:Ohkanda, Junko; Kusumoto, Atsushi; Punzalan, Louvy; Masuda, Ryoma; Wang, Chenyu; Parvatkar, Prakash; Akase, Dai; Aida, Misako; Uesugi, Motonari; Higuchi, Yusuke; Kato, Nobuo;


A Strategy of Designing Mid-sized Synthetic Molecules that Recognize Interfaces of Protein protein Interactions
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN,75(7):735-745 2017(Jul.)
Author:Ohkanda, Junko;


たんぱく質間相互作用を制御する合成分子の創製
京都大学化学研究所スーパーコンピュータシステム研究成果報告書,2016:7-7 2017(Mar.)
Author:大神田 淳子;


タンパク質を鋳型にして薬剤を創る:低分子の標的誘導型自己組織化によるタンパク質間相互作用の調節
化学と生物,55(11):724-726 2017
Author:大神田 淳子


Wiberg Bond Index 低原子価有機アルミニウム Ras蛋白 有機スズ高配位化錯体
有機合成化学協会誌,75(7):772-772 2017
Author:河内 敦; 吾郷 友宏; 大神田 淳子; 芝田 育也;


Protein-guided self-assembly for controlling protein-protein interactions
Journal of the Society of Japanese Women Scientists,17:1-7 2017
Author:Junko Ohkanda


たんぱく質間相互作用を制御する合成分子の創製
京都大学化学研究所スーパーコンピュータシステム研究成果報告書,2015:18-19 2015
Author:大神田 淳子;


Intracellular Generation of a Diterpene-Peptide Conjugate that Inhibits 14-3-3-Mediated Interactions
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,137(50):15624-15627 2015
Author:Parvatkar, Prakash; Kato, Nobuo; Uesugi, Motonari; Sato, Shin-ichi; Ohkanda, Junko;*


ペプチドミメティクス化
ファルマシア,50(11):1128_2-1128_2 2014
Author:大神田 淳子;


タンパク質間相互作用を阻害・検出する合成分子の創製
ファルマシア,50(11):1101-1106 2014
Author:大神田 淳子;


RNA-Directed Amino Acid Coupling as a Model Reaction for Primitive Coded Translation
CHEMBIOCHEM,15(6):794-798 2014
Author:Harada, Kazuo*; Aoyama, Shoko; Matsugami, Akimasa; Kumar, Penmetcha K. R.; Katahira, Masato; Kato, Nobuo; Ohkanda, Junko;


Module Assembly for Designing Multivalent Mid-Sized Inhibitors of Protein-Protein Interactions
CHEMICAL RECORD,13(6):561-575 2013(Dec.)
Author:Ohkanda, Junko;*


Stabilization of Physical RAF/14-3-3 Interaction by Cotylenin A as Treatment Strategy for RAS Mutant Cancers
ACS CHEMICAL BIOLOGY,8(9):1869-1875 2013(Sep.)
Author:Molzan, Manuela; Kasper, Stefan; Roeglin, Lars; Skwarczynska, Malgorzata; Sassa, Takeshi; Inoue, Takatsugu; Breitenbuecher, Frank; Ohkanda, Junko; Kato, Nobuo; Schuler, Martin; Ottmann, Christian;


Chemical ligation of epoxide-containing fusicoccins and peptide fragments guided by 14-3-3 protein
MOLECULAR BIOSYSTEMS,9(5):940-943 2013
Author:Maki, Toshio; Kawamura, Akie; Kato, Nobuo; Ohkanda, Junko;*


Antimicrobial N-(2-chlorobenzyl)-substituted hydroxamate is an inhibitor of 1-deoxy-D-xylulose 5-phosphate synthase
CHEMICAL COMMUNICATIONS,49(49):5535-5537 2013
Author:Hayashi, Daisuke; Kato, Nobuo; Kuzuyama, Tomohisa; Sato, Yasuo; Ohkanda, Junko;*


A Semisynthetic Fusicoccane Stabilizes a Protein-Protein Interaction and Enhances the Expression of K+ Channels at the Cell Surface
CHEMISTRY & BIOLOGY,20(4):583-593 2013
Author:Anders, Carolin; Higuchi, Yusuke; Koschinsky, Kristin; Bartel, Maria; Schumacher, Benjamin; Thiel, Philipp; Nitta, Hajime; Preisig-Mueller, Regina; Schlichthoerl, Guenter; Renigunta, Vijay; Ohkanda, Junko; Daut, Juergen; Kato, Nobuo; Ottmann, Christian;


Peptidomimetic modification improves cell permeation of bivalent farnesyltransferase inhibitors
BIOORGANIC & MEDICINAL CHEMISTRY,21(14):4004-4010 2013
Author:Machida, Shinnosuke; Tsubamoto, Mai; Kato, Nobuo; Harada, Kazuo; Ohkanda, Junko;


A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY,12(7):791-800 2012(Sep.)
Author:Kawakami, Koshi; Hattori, Miho; Inoue, Takatsugu; Maruyama, Yuriko; Ohkanda, Junko; Kato, Nobuo; Tongu, Miki; Yamada, Takaya; Akimoto, Miho; Takenaga, Keizo; Sassa, Takeshi; Suzumiy, Junji; Honma, Yoshio;


Phosphopeptide-Dependent Labeling of 14-3-3 zeta Proteins by Fusicoccin-Based Fluorescent Probes
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION,51(2):509-512 2012
Author:Takahashi, Michiko; Kawamura, Akie; Kato, Nobuo; Nishi, Tsuyoshi; Hamachi, Itaru; Ohkanda, Junko;*


Protein recognition of hetero-/homoleptic ruthenium(II) tris(bipyridine)s for alpha-chymotrypsin and cytochrome c
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,22(6):2354-2358 2012
Author:Yamaguchi, Yoshinobu; Kato, Nobuo; Azuma, Hideki; Nagasaki, Takeshi; Ohkanda, Junko;*


Bivalent Inhibitors for Disrupting Protein Surface-Substrate Interactions and for Dual Inhibition of Protein Prenyltransferases
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,133(4):958-963 2011
Author:Machida, Shinnosuke; Kato, Nobuo; Harada, Kazuo; Ohkanda, Junko;*


クロロキン耐性P. falciparumに対するダブルパンチ型抗マラリア剤(G 医薬化学)
ファルマシア,46(1):80-81 2010(Jan. 01)
Author:大神田 淳子;


ビピリジン金属錯体によるセリンプロテアーゼの表面認識と阻害活性
ホスト・ゲスト化学シンポジウム講演要旨集,2009:14-14 2009
Author:大神田 淳子; 藤井 康平; 山口 佳史; 加藤 修雄;
Keywords:ビピリジン金属錯体; たんぱく質表面認識; セリンプロテアーゼ; 酵素活性阻害; モジュールアセンブリ;


Protein surface recognition by dendritic ruthenium(II) tris(bipyridine) complexes
CHEMICAL COMMUNICATIONS,(45):6949-6951 2009
Author:Ohkanda, Junko; Satoh, Ritsuko; Kato, Nobuo;


Structurally Simple Inhibitors of Lanosterol 14 alpha-Demethylase Are Efficacious In a Rodent Model of Acute Chagas Disease
JOURNAL OF MEDICINAL CHEMISTRY,52(12):3703-3715 2009
Author:Suryadevara, Praveen Kumar; Olepu, Srinivas; Lockman, Jeffrey W.; Ohkanda, Junko; Karimi, Mandana; Verlinde, Christophe L. M. J.; Kraus, James M.; Schoepe, Jan; Van Voorhis, Wesley C.; Hamilton, Andrew D.; Buckner, Frederick S.; Gelb, Michael H.;


Transannular Proton Transfer in the Cyclization of Geranylgeranyl Diphosphate to Fusicoccadiene, a Biosynthetic Intermediate of Fusicoccins
ORGANIC LETTERS,11(14):3044-3047 2009
Author:Toyomasu, Tomonobu; Tsukahara, Mai; Kenmoku, Hiromichi; Anada, Masahide; Nitta, Hajime; Ohkanda, Junko; Mitsuhashi, Wataru; Sassa, Takeshi; Kato, Nobuo;


Design and functional evaluation of dual prenyltransferase inhibitors for simultaneous recognition of active site and exterior protein surface
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,238 2009
Author:Machida, Shinnosuke; Kato, Nobuo; Harada, Kazuo; Ohkanda, Junko;


Module assembly for protein-surface recognition: Geranylgeranyltransferase I bivalent inhibitors for simultaneous targeting of interior and exterior protein surfaces
CHEMISTRY-A EUROPEAN JOURNAL,14(5):1392-1401 2008
Author:Machida, Shinnosuke; Usuba, Kakeru; Blaskovich, Michelle A.; Yano, Akiko; Harada, Kazuo; Sebti, Said M.; Kato, Nobuo; Ohkanda, Junko;


Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter
ONCOGENE,26(5):633-640 2007(Feb.)
Author:Delarue, F. L.; Adnane, J.; Joshi, B.; Blaskovich, M. A.; Wang, D-A; Hawker, J.; Bizouarn, F.; Ohkanda, J.; Zhu, K.; Hamilton, A. D.; Chellappan, S.; Sebti, S. M.;


ORGN 129-Bivalent inhibitors of Type-I geranylgeranyltransferase for simultaneous recognition of interior and exterior protein surfaces
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,234 2007
Author:Ohkanda, Junko; Machida, Shinnosuke; Kato, Nobuo; Blaskovich, Michelle A.; Sebti, Saied M.; Harada, Kazuo;


Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase
ORGANIC & BIOMOLECULAR CHEMISTRY,4(3):482-492 2006
Author:Ohkanda, J; Strickland, CL; Blaskovich, MA; Carrico, D; Lockman, JW; Vogt, A; Bucher, CJ; Sun, JZ; Qian, YM; Knowles, D; Pusateri, EE; Sebti, SM; Hamilton, AD;


Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents
JOURNAL OF MEDICINAL CHEMISTRY,47(2):432-445 2004
Author:Ohkanda, J; Buckner, FS; Lockman, JW; Yokoyama, K; Carrico, D; Eastman, R; de Luca-Fradley, K; Davies, W; Croft, SL; Van Voorhis, WC; Gelb, MH; Sebti, SM; Hamilton, AD;


In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability
BIOORGANIC & MEDICINAL CHEMISTRY,12(24):6517-6526 2004
Author:Carrico, D; Ohkanda, J; Kendrick, H; Yokoyama, K; Blaskovich, MA; Bucher, CJ; Buckner, FS; Van Voorhis, WC; Chakrabarti, D; Croft, SL; Gelb, MH; Sebti, SM; Hamilton, AD;


In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus
JOURNAL OF CLINICAL INVESTIGATION,112(3):407-414 2003(Aug.)
Author:Bordier, BB; Ohkanda, J; Liu, P; Lee, SY; Salazar, FH; Marion, PL; Ohashi, K; Meuse, L; Kay, MA; Casey, JL; Sebti, SM; Hamilton, AD; Glenn, JS;


The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells
LEUKEMIA,17(2):451-457 2003(Feb.)
Author:Bolick, SCE; Landowski, TH; Boulware, D; Oshiro, MM; Ohkanda, J; Hamilton, AD; Sebti, SM; Dalton, WS;


A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,100(25):15149-15153 2003
Author:Buckner, F; Yokoyama, K; Lockman, J; Aikenhead, K; Ohkanda, J; Sadilek, M; Sebti, S; Van Voorhis, W; Hamilton, A; Gelb, MH;


Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice
CANCER RESEARCH,63(24):8922-8929 2003
Author:Sun, JZ; Ohkanda, J; Coppola, D; Yin, H; Kothare, M; Busciglio, B; Hamilton, AD; Sebti, SM;


The farnesyltransferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation status
CELL DEATH AND DIFFERENTIATION,9(7):702-709 2002(Jul.)
Author:Crespo, NC; Delarue, F; Ohkanda, J; Carrico, D; Hamilton, AD; Sebti, SM;


CAAX peptidomimetics: Their farnesyltransferase inhibition activity and antitumor effect
SEIKAGAKU,74(1):46-50 2002(Jan.)
Author:Ohkanda, J;


Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffold
JOURNAL OF MEDICINAL CHEMISTRY,45(1):177-188 2002
Author:Ohkanda, J; Lockman, JW; Kothare, MA; Qian, YM; Blaskovich, MA; Sebti, SM; Hamilton, AD;


Prenyltransferase inhibitors as antitumor and antiparasitic agents: Rational design based on CAAX peptide and solution phase combinatorial approaches.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,224:U30-U30 2002
Author:Ohkanda, J; Lockman, JW; Carrico, D; Strickland, CL; Sebti, SM; Gelb, MH; Hamilton, AD;


Design, synthesis and evaluation of peptidomimetic farnesyltransferase inhibitor ester pro-drugs as potent antiparasitic agents.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,224:U28-U28 2002
Author:Carrico, D; Ohkanda, J; Gelb, MH; Blaskovich, MA; Sebti, SM; Hamilton, AD;


Toward Chagas disease chemotherapeutics: Development of simple compounds active against Trypanosoma cruzi.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,224:U17-U17 2002
Author:Lockman, JW; Ohkanda, J; Yokoyama, K; Eastman, RT; Buckner, FS; Gelb, MH; Hamilton, AD;


Synthesis of linear and cyclic hexapeptides with N epsilon-(1,2-dihydro-1-hydroxy-2-oxopyrimidin-4-yl)-L-lysyl-beta-alanyl as the repeating unit and properties of their iron(III) complexes
HETEROCYCLES,58:371-381 2002
Author:Katoh, A; Inoue, Y; Nagashima, H; Hikita, Y; Ohkanda, J; Saito, R;


Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,11(6):761-764 2001
Author:Ohkanda, J; Lockman, JW; Yokoyama, K; Gelb, MH; Croft, SL; Kendrick, H; Harrell, MI; Feagin, JE; Blaskovich, MA; Sebti, SM; Hamilton, AD;


The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells
JOURNAL OF BIOLOGICAL CHEMISTRY,276(19):16161-16167 2001
Author:Crespo, NC; Ohkanda, J; Yen, TJ; Hamilton, AD; Sebti, SM;


3-hydroxy-4(1H)-pyridinone-containing linear and cyclic hexapeptides and their iron(III) complexes - Synthesis, property, and the growth-promotion activity-
HETEROCYCLES,55(11):2171-2187 2001
Author:Katoh, A; Hikita, Y; Harata, M; Ohkanda, J; Tsubomura, T; Higuchi, A; Saito, R; Harada, K;


Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
CARCINOGENESIS,21(1):113-116 2000(Jan.)
Author:Lantry, LE; Zhang, ZQ; Yao, RS; Crist, KA; Wang, Y; Ohkanda, J; Hamilton, AD; Sebti, SM; Lubet, RA; You, M;


Synthesis of quinoxaline derivatives bearing the styryl and phenylethynyl groups and application to a fluorescence derivatization reagent
HETEROCYCLES,52(2):911-920 2000
Author:Katoh, A; Yoshida, T; Ohkanda, J;


Inhibition of farnesyltransferase increases TGF beta type II receptor expression and enhances the responsiveness of human cancer cells to TGF beta
ONCOGENE,19(48):5525-5533 2000
Author:Adnane, J; Bizouarn, FA; Chen, Z; Ohkanda, J; Hamilton, AD; Munoz-Antonia, T; Sebti, SM;


Development of a tripeptide mimetic strategy for the inhibition of protein farnesyltransferase
TETRAHEDRON,56(50):9833-9841 2000
Author:Kothare, MA; Ohkanda, J; Lockman, JW; Qian, YM; Blaskovich, MA; Sebti, SM; Hamilton, AD;


Synthesis of 6-(bromoacetyl)amino-2,3-dimorpholinoquinoxaline and application to a new fluorescence derivatization reagent of fatty acids for the high-performance liquid chromatographic analysis
HETEROCYCLES,50(1):299-308 1999
Author:Katoh, A; Fujimoto, T; Takahashi, M; Ohkanda, J;


Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I
JOURNAL OF MEDICINAL CHEMISTRY,42(8):1333-1340 1999
Author:Vasudevan, A; Qian, YM; Vogt, A; Blaskovich, MA; Ohkanda, J; Sebti, SM; Hamilton, AD;


Novel nonthiol inhibitors of farnesyl transferase show potent antitumor properties.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,218:U984-U984 1999
Author:Ohkanda, J; Blaskovich, M; Sun, J; Sebti, SM; Hamilton, AD;


Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: Combination therapy with the cytotoxic agents cisplatin, taxol, and gemcitabine
CANCER RESEARCH,59(19):4919-4926 1999
Author:Sun, JZ; Blaskovich, MA; Knowles, D; Qian, YM; Ohkanda, J; Bailey, RD; Hamilton, AD; Sebti, SM;


N-hydroxyamide-containing heterocycles: Synthesis, reactivities, and iron(III)-chelating properties
REVIEWS ON HETEROATOM CHEMISTRY,18:87-118 1998
Author:Ohkanda, J; Katoh, A;


N-hydroxypyrazinone-bearing homotrioxacalix[3]arene: its cooperative molecular recognition by metal complexation
CHEMICAL COMMUNICATIONS,(3):375-376 1998
Author:Ohkanda, J; Shibui, H; Katoh, A;


Requirement for geranylgeranyl transferase I and acyl transferase in the TGF-beta-stimulated pathway leading to elastin mRNA stabilization
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,252(1):111-116 1998
Author:Kucich, U; Rosenbloom, JC; Shen, G; Abrams, WR; Blaskovich, MA; Hamilton, AD; Ohkanda, J; Sebti, SM; Rosenbloom, J;


New hexadentate ligands composed of 1-hydroxy-2(1H)-pyrimidinone, alpha,omega-diamine and 1,1,1-tris(carboxyethoxymethyl)-ethane or tri(carboxybutyl)isocyanurate. Synthesis and characterization of their iron(III) complexes
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS,(22):3859-3864 1998
Author:Katoh, A; Hida, Y; Kamitani, J; Ohkanda, J;


Synthesis of 2,2 '-bipyridines bearing amino or carboxyl group at the side chain and physical properties of their ruthenium(II) complexes
HETEROCYCLES,49:281-296 1998
Author:Katoh, A; Kitamura, Y; Fujii, H; Horie, Y; Satoh, T; Ohkanda, J; Yokomori, Y;


Functionalized N-hydroxyamide-containing heterocycles - Synthesis, reaction, and metal-chelating property
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN,55(6):524-534 1997(Jun.)
Author:Ohkanda, J; Katoh, A;


Structural analysis of N-(omega-phenylalkyl)substituted quinoxalin-2(1H)-ones and -thiones
HETEROCYCLES,44:357-366 1997
Author:Katoh, A; Yoshida, T; Ohkanda, J; Nishio, T;


Novel iron sequestering agents: Synthesis and iron-chelating properties of hexadentate ligands composed of 1-hydroxy-2(1H)-pyrimidinone, omega-amino carboxylic acid, and tris(2-aminoethyl)amine
JOURNAL OF ORGANIC CHEMISTRY,62(11):3618-3624 1997
Author:Ohkanda, J; Kamitani, J; Tokumitsu, T; Hida, Y; Konakahara, T; Katoh, A;


Synthesis of 1,3-linked 1,4-dihydropyridines containing the L-tyrosine residue and the influence of their structures upon the enantioselective reduction
HETEROCYCLES,45(8):1441-1446 1997
Author:Katoh, A; Naruse, S; Ohkanda, J; Yamamoto, H;


N-hydroxyamide-containing heterocycles .6. Application of 1-hydroxy-4,6-dimethyl-2(1H)-pyrimidinone to a new benzyloxycarbonylating agent
HETEROCYCLIC COMMUNICATIONS,2(2):141-144 1996
Author:Katoh, A; Kondoh, S; Ohkanda, J;


The influence of the chirality of synthetic iron chelators bearing N-hydroxy-2(1H)-pyrazinones and amino acid residues upon iron removal from human transferrin
CHEMISTRY LETTERS,(6):423-424 1996
Author:Ohkanda, J; Katoh, A;


Synthesis of 2,3-disubstituted 6-aminoquinoxalines and their application to new fluorescence derivatization reagents for carboxylic acids
CHEMISTRY LETTERS,(5):369-370 1996
Author:Katoh, A; Takahashi, M; Ohkanda, J;


Synthesis of novel amphiphilic compounds containing aza-12-crown-4 or D-glucosamine and their ion permeability
HETEROCYCLES,43(3):589-599 1996
Author:Katoh, A; Ishida, S; Ohkanda, J; Washizu, M;


N-hydroxyamide-containing heterocycles .7. Preparation and photochemical behavior of 1-benzyloxy-2(1H)-pyrazinones
HETEROCYCLES,43(4):883-889 1996
Author:Ohkanda, J; Kumasaka, T; Takasu, A; Hasegawa, T; Katoh, A;


N-HYDROXYAMIDE-CONTAINING HETEROCYCLES .4. SYNTHESIS AND FE-III-CHELATING PROPERTIES OF NOVEL HEXADENTATE LIGANDS COMPOSED OF N-HYDROXY-2(1H)-PYRAZINONE, AMINO-ACID-RESIDUES, AND TRIS(2-AMINOETHYL)AMINE
JOURNAL OF ORGANIC CHEMISTRY,60(6):1583-1589 1995
Author:OHKANDA, J; KATOH, A;


N-HYDROXYAMIDE-CONTAINING HETEROCYCLES .5. SYNTHESIS OF NOVEL HEXADENTATE LIGANDS COMPOSED OF N-HYDROXY-2(1H)-PYRAZINONE, ALIPHATIC DIAMINE, AND 1,1,1-TRIS(CARBOXYETHOXYMETHYL)ETHANE, AND PROPERTIES OF THEIR FERRIC COMPLEXES
TETRAHEDRON,51(47):12995-13002 1995
Author:OHKANDA, J; KATOH, A;


SYNTHESIS OF 2(1H)-PYRIMIDINONE-CONTAINING ALPHA-AMINO-ACID DERIVATIVES BY CHEMICAL MODIFICATION OF L-GLUTAMIC ACID
CHEMICAL & PHARMACEUTICAL BULLETIN,42(7):1514-1517 1994(Jul.)
Author:KATOH, A; INOKAWA, M; OHKANDA, J; MITSUHASHI, K;


N-HYDROXYAMIDE-CONTAINING HETEROCYCLES .3. THE RING TRANSFORMATION OF 1-BENZYLOXY-2(1H)-PYRIMIDINONES INTO 2-ISOXAZOLINES WITH HYDROXYLAMINE
HETEROCYCLES,37(2):1141-1146 1994
Author:KATOH, A; OHKANDA, J; TAMURA, A; YOSHIIKE, Y; MITSUHASHI, K;


N-HYDROXYAMIDE-CONTAINING HETEROCYCLES .2. SYNTHESIS AND IRON(III) COMPLEX-FORMING TENDENCY OF 1-HYDROXY-2(1H)-PYRIMIDINONE AND 1-HYDROXY-2(1H)-PYRAZINONE
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN,66(3):841-847 1993(Mar.)
Author:OHKANDA, J; TOKUMITSU, T; MITSUHASHI, K; KATOH, A;


A CONVENIENT SYNTHESIS OF 3-(ARYL)SUBSTITUTED 2,4(1H,3H)-PTERIDINEDIONES AND THEIR ABSORPTION AND FLUORESCENCE SPECTROSCOPIC CHARACTERISTICS
HETEROCYCLES,35(2):949-954 1993
Author:KATOH, A; OHKANDA, J; SATO, H; SAKAMOTO, T; MITSUHASHI, K;


N-HYDROXYAMIDE-CONTAINING HETEROCYCLES - NEW EFFECTIVE ADDITIVES FOR PEPTIDE-SYNTHESIS BY THE DICYCLOHEXYLCARBODIIMIDE METHOD
CHEMISTRY LETTERS,(10):2009-2012 1992(Oct.)
Author:KATOH, A; OHKANDA, J; ITOH, Y; MITSUHASHI, K;


STRUCTURAL ASPECTS OF THE MECHANICAL AND THERMAL-DISSOCIATION OF THE CENTRAL BOND IN 2,2'-BIS(2,3,4-TRIARYLCHROMENYL)S
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2,(1):59-63 1992(Jan.)
Author:OHKANDA, J; MORI, Y; MAEDA, K; OSAWA, E;


UNUSUAL SUBSTITUENT EFFECT BY THE ALPHA-ACETYL GROUP ON THE TYPE-II PHOTOREACTION OF VALEROPHENONES - STRONG WAVELENGTH DEPENDENCE OF QUANTUM YIELDS
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY,64(3):299-306 1992
Author:HASEGAWA, T; OHKANDA, J; KOBAYASHI, M; YOSHIOKA, M;


ISOLATION OF THE INTERMEDIATES AND IMPROVED SYNTHESIS OF PYRIDO[1',2'/1,2]IMIDAZOL[4,5-B]PYRAZINES AND PYRIDO[1',2'/1,2]IMIDAZOL]4,5-B]QUINOXALINES
HETEROCYCLES,34(10):1965-1972 1992
Author:KATOH, A; UEDA, SH; OHKANDA, J; HIROTA, M; KOMINE, H; MITSUHASHI, K;